Literature DB >> 16740088

Characterization of canine mitochondrial protein expression in natural and induced forms of idiopathic dilated cardiomyopathy.

Rosana Lopes1, Philip F Solter, D David Sisson, Mark A Oyama, Robert Prosek.   

Abstract

OBJECTIVE: To map canine mitochondrial proteins and identify qualitative and quantitative differences in heart mitochondrial protein expression between healthy dogs and dogs with naturally occurring and induced dilated cardiomyopathy (DCM). SAMPLE POPULATION: Left ventricle samples were obtained from 7 healthy dogs, 7 Doberman Pinschers with naturally occurring DCM, and 7 dogs with induced DCM. PROCEDURES: Fresh and frozen mitochondrial fractions were isolated from the left ventricular free wall and analyzed by 2-dimensional electrophoresis. Protein spots that increased or decreased in density by >or= 2-fold between groups were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or quadrupole selecting, quadrupole collision cell, time-of-flight mass spectrometry.
RESULTS: Within narrow pH gradients of control canine heart mitochondrial samples, a total of 1,528 protein spots were revealed. Forty subunits of heart mitochondrial proteins that differ significantly from control tissues were altered in tissue specimens from dogs with naturally occurring and induced forms of DCM. The most affected heart mitochondrial proteins in both groups were those of oxidative phosphorylation (55%). Upregulation of manganese superoxide dismutase was suggestive of heart oxidative injury in tissue specimens from dogs with both forms of DCM. Evidence of apoptosis was associated with overexpression of the heart mitochondrial voltage-dependent anion channel-2 protein and endonuclease G in tissue specimens from dogs with induced DCM. CONCLUSIONS AND CLINICAL RELEVANCE: Alterations of heart mitochondrial proteins related to oxidative phosphorylation dysfunction were more prevalent in tissue specimens from dogs with induced or naturally occurring DCM, compared with those of control dogs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740088     DOI: 10.2460/ajvr.67.6.963

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher.

Authors:  Kathryn M Meurs; Sunshine Lahmers; Bruce W Keene; Stephen N White; Mark A Oyama; Evan Mauceli; Kerstin Lindblad-Toh
Journal:  Hum Genet       Date:  2012-03-25       Impact factor: 4.132

2.  Quantitative proteomic analysis reveals novel mitochondrial targets of estrogen deficiency in the aged female rat heart.

Authors:  T S Lancaster; S J Jefferson; J Craig Hunter; Veronica Lopez; J E Van Eyk; E G Lakatta; D H Korzick
Journal:  Physiol Genomics       Date:  2012-08-28       Impact factor: 3.107

3.  Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.

Authors:  Dilek Colak; Namik Kaya; Jawaher Al-Zahrani; Albandary Al Bakheet; Paul Muiya; Editha Andres; John Quackenbush; Nduna Dzimiri
Journal:  Genomics       Date:  2009-03-28       Impact factor: 5.736

4.  Evaluation of a high-sensitivity cardiac troponin I assay compared to a first-generation cardiac troponin I assay in Doberman Pinschers with and without dilated cardiomyopathy.

Authors:  Lena Klüser; Elizabeth T Maier; Gerhard Wess
Journal:  J Vet Intern Med       Date:  2018-12-11       Impact factor: 3.333

5.  Functional Consequences of PDK4 Deficiency in Doberman Pinscher Fibroblasts.

Authors:  Luiz Bolfer; Amara H Estrada; Chelsea Larkin; Thomas J Conlon; Francisco Lourenco; Kathryn Taggart; Silveli Suzuki-Hatano; Christina A Pacak
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

6.  Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.

Authors:  Yujiao Yang; Ping Liu; Ruoling Teng; Fenfen Liu; Cuiping Zhang; Xiang Lu; Yi Ding
Journal:  Ann Transl Med       Date:  2022-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.